The treatment of lupus nephritis.
D'Cruz
David P
DP
Hughes
Graham R V
GR
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D003520:Cyclophosphamide / Q000627:therapeutic use; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D008181:Lupus Nephritis / Q000188:drug therapy*; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000069283:Rituximab
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D016756:Immunoglobulins, Intravenous; D000069283:Rituximab; D003520:Cyclophosphamide; D009173:Mycophenolic Acid
N Engl J Med. 2004 Mar 4;350(10):971-80
14999109
Clin Exp Rheumatol. 1997 May-Jun;15(3):275-82
9177922
Lupus. 2004;13(12):887-90
15645741
Medicine (Baltimore). 2000 Jan;79(1):57-68
10670410
N Engl J Med. 2000 Oct 19;343(16):1156-62
11036121
Ann Rheum Dis. 2003 Oct;62(10):999-1002
12972481
Arthritis Rheum. 2002 Oct;46(10):2673-7
12384926
J Rheumatol. 2003 May;30(5):985-92
12734893
J Nephrol. 2003 Mar-Apr;16(2):161-7
12768062
N Engl J Med. 2003 Jul 3;349(1):36-44
12840090
Arthritis Rheum. 2002 Aug;46(8):2121-31
12209517